Are there differences among anti-TNFα biological drugs?;Esistono delle differenze tra i farmaci biologici anti-TNFα?

Reumatismo

Volumn 57, Issue SUPPL. 4, 2005, Pages 1-2

  Valesini, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Drugs; Rheumatic diseases; Tumor Necrosis Factor alpha

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

CLINICAL PRACTICE; DRUG ACTIVITY; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; IMMUNE SYSTEM; MATHEMATICAL ANALYSIS; NEUROENDOCRINE SYSTEM; REVIEW; STATISTICAL ANALYSIS; TREATMENT INDICATION;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; HUMANS; IMMUNOGLOBULIN G; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RHEUMATIC DISEASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846639613     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (7)

1. Furst DE. Are there differences among nonsteroideal antinflammatory drugs? Arthritis Rheum 1994; 37: 1-19.
2. McAlister FA, Laupacis A, Wells GA, Sackett DL, for the Evidence-Based Medicine Working Group. Users' guide to the medical literature XIX. Applying clinical trial results. B. Guidelines for determining whether a drug is exerting (more than) a class effect. JAMA 1999; 282: 1371-7.
3. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol 1997; 50: 683-91.
4. Mikuls TR, Moreland LW. TNF blockade in the treatment of rheumatoid arthritis: infliximab versus etanercept. Expet Opinion on Pharmacotherapy 2001; 2: 75-84.
5. Hochberg MC, Tracy JK, Hawkins-Holt M, Flores RH. Comparison of the efficacy of the tumour necrosis factor α blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis. Ann Rheum Dis 2003; 62 (Suppl II): ii13-ii16.
6. Schwartzman S, Morgan GJ. Does route of administration affect the outcome of TNF antagonist therapy? Arthritis Res Ther 2004; 6 (Suppl 2): S19-S23.
7. Schwartzman S, Fleischmann R, Morgan GJ. Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis? Arthritis Res Ther 2004; 6 (Suppl 2): S3-S11.